Fabrizio Ricci

Zisis Kozlakidis

Longxiang Su

Thomas Rawson

Marco Iosa

Catherine Ropert

Jonathan Kantor

Constantinos Tsioutis

Susan Christina Welburn

Burc Barin

Jiufeng Sun

Eugenie Ruth Lumbers

Almost nine months since the first recorded case, the novel betacoronovirus; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has now passed 18 million confirmed cases. The multi-disciplinary work of researchers worldwide has provided a far deeper understanding of COVID-19 pathogenesis, clinical treatment and outcomes, lethality, disease-spread dynamics, period of infectivity, containment interventions, as well as providing a wealth of relevant epidemiological data. With 27 vaccines currently undergoing human trials, and countries worldwide continuing to battle case numbers, or prepare for resurgences, the need for efficient, high-quality pipelines for peer-reviewed research remains as crucial as ever.

Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response, Volume II (volume I.A)

Marco Iosa

About

Books

Join the club